Literature DB >> 1721365

FK 506 conversion of renal allografts failing cyclosporine immunosuppression.

M L Jordan1, R Shapiro, C W Jensen, V Scantlebury, J Fung, A Tzakis, J McCauley, A Jain, J Demetrius, P Randhawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1721365      PMCID： PMC2967307     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  13 in total

1.  Early trials with FK 506 as primary treatment in liver transplantation.

Authors:  S Todo; J J Fung; A J Demetris; A Jain; R Venkataramanan; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

2.  Kidney transplantation under FK 506 immunosuppression.

Authors:  R Shapiro; M Jordan; J Fung; J McCauley; J Johnston; Y Iwaki; A Tzakis; T Hakala; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

3.  Long-term results of cyclosporine treatment in renal transplantation.

Authors:  N L Tilney; E L Milford; C B Carpenter; J M Lazarus; T B Strom; R L Kirkman
Journal:  Transplant Proc       Date:  1986-04       Impact factor: 1.066

4.  A highly sensitive method to assay FK-506 levels in plasma.

Authors:  K Tamura; M Kobayashi; K Hashimoto; K Kojima; K Nagase; K Iwasaki; T Kaizu; H Tanaka; M Niwa
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

5.  Kidney transplantation under FK 506.

Authors:  T E Starzl; J Fung; M Jordan; R Shapiro; A Tzakis; J McCauley; J Johnston; Y Iwaki; A Jain; M Alessiani
Journal:  JAMA       Date:  1990-07-04       Impact factor: 56.272

6.  Sequential antilymphoblast globulin and cyclosporine for renal transplantation.

Authors:  B G Sommer; M Henry; R M Ferguson
Journal:  Transplantation       Date:  1987-01       Impact factor: 4.939

7.  Individualization of immediate posttransplant immunosuppression. The value of antilymphocyte globulin in patients with delayed graft function.

Authors:  A J Matas; V A Tellis; T A Quinn; D Glicklich; R Soberman; F J Veith
Journal:  Transplantation       Date:  1988-02       Impact factor: 4.939

8.  A randomized prospective trial comparing cyclosporine monotherapy with triple-drug therapy in renal transplantation.

Authors:  A Tarantino; A Aroldi; L Stucchi; G Montagnino; L Mascaretti; A Vegeto; C Ponticelli
Journal:  Transplantation       Date:  1991-07       Impact factor: 4.939

9.  Cyclosporin in cadaveric renal transplantation: one-year follow-up of a multicentre trial.

Authors: 
Journal:  Lancet       Date:  1983-10-29       Impact factor: 79.321

10.  A randomized clinical trial of cyclosporine in cadaveric renal transplantation.

Authors: 
Journal:  N Engl J Med       Date:  1983-10-06       Impact factor: 91.245
View more
  15 in total

1.  Outcome of tacrolimus conversion therapy for renal allograft rejection: 5-year follow-up.

Authors:  M L Jordan; R Shapiro; C Vivas; V Scantlebury; J McCauley; J McMichael; P Randhawa; A Demetris; J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1999-11       Impact factor: 1.066

2.  Overview of FK506 in transplantation.

Authors:  J J Fung; K Abu-Elmagd; S Todo; R Shapiro; A Tzakis; M Jordan; J Armitage; A Jain; M Alessiani; M Martin
Journal:  Clin Transpl       Date:  1990

3.  The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine.

Authors:  P S Randhawa; R Shapiro; M L Jordan; T E Starzl; A J Demetris
Journal:  Am J Surg Pathol       Date:  1993-01       Impact factor: 6.394

4.  Two-year experience with FK 506 in pediatric patients.

Authors:  A G Tzakis; J Reyes; S Todo; B Nour; R Shapiro; M Jordan; J McCauley; J Armitage; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

5.  FK 506 salvage of renal allografts with ongoing rejection failing cyclosporine immunosuppression.

Authors:  M L Jordan; R Shapiro; C A Vivas; V P Scantlebury; F S Darras; G Carrieri; J McCauley; A J Demetris; P Randhawa; C Jensen
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

6.  Tacrolimus for rescue of refractory renal allograft rejection.

Authors:  M L Jordan; R Naraghi; R Shapiro; D Smith; C A Vivas; V P Scantlebury; H A Gritsch; J McCauley; P Randhawa; A J Demetris; J McMichael; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1998-06       Impact factor: 1.066

7.  Tacrolimus rescue therapy for renal transplant rejection.

Authors:  M L Jordan; R Shapiro; R Naraghi; D Smith; C Vivas; H A Gritsch; V Scantlebury; P Randhawa; A J Demetris; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1996-08       Impact factor: 1.066

Review 8.  Kidney transplantation in highly sensitized patients: reappraisal of etiology, evaluation, and management protocols.

Authors:  R Indudhara; R B Khauli
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

9.  Renal transplantation at the University of Pittsburgh: the impact of FK506.

Authors:  R Shapiro; M Jordan; V P Scantlebury; C Vivas; H A Gritsch; A S Rao; M Trucco; A Zeevi; A J Demetris; P Randhawa
Journal:  Clin Transpl       Date:  1994

Review 10.  FK506 in solid organ transplantation.

Authors:  J J Fung; T E Starzl
Journal:  Ther Drug Monit       Date:  1995-12       Impact factor: 3.681
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.